Evidence map›Paper›PMID 38322471›Full record

ArticleWorld journal of clinical cases2024

Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome.

Wiem Manoubi, Marwa Mahdouani, Dorra Hmida, Ameni Kdissa, Aida Rouissi, Ilhem Turki, Neji Gueddiche, Najla Soyah, Ali Saad, Christian Bouwkamp and 3 more

Abstract read
In one paragraph

Article in World journal of clinical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wiem ManoubiLaboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Sousse 4000, Tunisia.
Marwa MahdouaniLaboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Sousse 4000, Tunisia.
Dorra HmidaLaboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Sousse 4000, Tunisia.
Ameni KdissaLaboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Sousse 4000, Tunisia.
Aida RouissiDepartment of Neuropediatry, La Rabta Hospital, Tunis 2000, Tunisia.
Ilhem TurkiDepartment of Neuropediatry, La Rabta Hospital, Tunis 2000, Tunisia.
Neji GueddicheDepartment of Pediatric, Fattouma Bourguiba Hospital Monastir, Monastir 2003, Tunisia.
Najla SoyahDepartment of Pediatric, Farhat Hached University Hospital, Sousse 4000, Tunisia.
Ali SaadLaboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Sousse 4000, Tunisia.
Christian BouwkampDepartment of Neuroscience, Erasmus MC, the Netherlands, Rotterdam 3112 td, Netherlands.
Ype ElgersmaDepartment of Neuroscience, Erasmus MC, the Netherlands, Rotterdam 3112 td, Netherlands.
Soumaya Mougou-ZerelliLaboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Sousse 4000, Tunisia.
Moez GribaaLaboratory of Human Cytogenetics, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Sousse 4000, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAngelman syndrome (AS) is caused by maternal chromosomal deletions, imprinting defects, paternal uniparental disomy involving chromosome 15 and the ubiquitin-protein ligase

aimTo investigate the involvement of

methodsWe established a cohort study in 50 patients referred to Farhat Hached University Hospital between 2006 and 2021, with a strong suspicion of AS and absence of chromosomal aberrations. The

resultsWe describe seven

conclusionScreening for

Indexed as

Angelman syndromeConsanguinityExomePolymorphismUbiquitin-protein ligase E3A

Identifiers

PMID38322471
PMCPMC10841941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.